Page last updated: 2024-10-30

metformin and Neurilemoma

metformin has been researched along with Neurilemoma in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Aspirin has also been associated with decreased VS growth in animal studies."1.91Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model. ( Burns, A; Hartman, Y; Hunter, JB; Killeen, DE; Lora Gonzalez, MA; Manickavel, S; Walsh, E; Warram, J, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Manickavel, S1
Hartman, Y1
Burns, A1
Lora Gonzalez, MA1
Warram, J1
Walsh, E1
Hunter, JB1
Killeen, DE1

Other Studies

1 other study available for metformin and Neurilemoma

ArticleYear
Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2023, 10-01, Volume: 44, Issue:9

    Topics: Animals; Aspirin; Metformin; Mice; Mice, Nude; Neurilemmoma; Neuroma, Acoustic; Rats

2023